| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/08/2013 | US8349355 Formulations of lipoic acid and hyaluroinc acid and/or the derivatives thereof in the pharmaceutical and cosmetic fields |
| 01/08/2013 | US8349353 Controlled release cytotoxic agent compositions and methods for the treatment of otic disorders |
| 01/08/2013 | US8349317 Use of L-carnitine or an alkanoyl L-carnitine, for the preparation of a dietary supplement or medicament for the treatment of corneal disease |
| 01/08/2013 | US8349309 Polymeric coupling agents and pharmaceutically-active polymers made therefrom |
| 01/08/2013 | US8349308 Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereof |
| 01/08/2013 | US8349307 Polymer conjugates of opioid antagonists |
| 01/08/2013 | US8349306 Hydrophilic comonomers of alkylene glycol, vinyl alcohols, vinylpyrrolidone, and/or acrylamide; hydrophobic comonoomer of lactic acid, glycolic acid, 6-hydroxycaproic acid, and/or dioxan-2-one substituted with tocopherol or cholesterol; stable micelles for delivery of anticarcinogenic agents |
| 01/08/2013 | US8349305 Crosslinked amine polymers |
| 01/08/2013 | US8349304 Evaporative cooling composition |
| 01/08/2013 | US8349303 Polymeric quaternium compounds |
| 01/08/2013 | US8349295 Surface modified aerosol particles, a method and apparatus for production thereof and powders and dispersions containing said particles |
| 01/08/2013 | CA2742783C Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 01/08/2013 | CA2710224C Novel dihydroindolone derivatives, method for production thereof and pharmaceutical compositions comprising said derivatives |
| 01/08/2013 | CA2707681C Pharmaceutical preparation for treating demyelinating diseases of the nervous system; preparation promoting restoration of the myelin sheath of nerve fibers; and a method for treating demyelinating diseases of the nervous system |
| 01/08/2013 | CA2701110C Bicyclic .gamma.-amino acid derivative |
| 01/08/2013 | CA2698528C Animal parasite-control method using insect growth regulators |
| 01/08/2013 | CA2696826C Process for preparing inhibitors of nucleoside metabolism |
| 01/08/2013 | CA2690001C Substituted benzoylamino-indan-2-carboxylic acids and related compounds |
| 01/08/2013 | CA2684556C Novel therapeutic uses of 4-[2-(4-methylphenylsulfanyl)-phenyl]piperidine |
| 01/08/2013 | CA2683751C Substituted biphenyl phenoxy-, thiophenyl- and aminophenylpropanoic acid gpr40 modulators |
| 01/08/2013 | CA2677315C Pyrimidinylaminobenzamide derivatives and their use as inhibitors of tyrosine kinases |
| 01/08/2013 | CA2677176C Inhibition of bcl-2 protein expression by liposomal antisense oligodeoxynucleotides |
| 01/08/2013 | CA2662000C Thiophene pyrazolopyrimidine compounds |
| 01/08/2013 | CA2660760C Fluoroalkoxycombretastatin derivatives, methods for producing same and use thereof |
| 01/08/2013 | CA2660153C Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of sirna |
| 01/08/2013 | CA2658950C New macrolides useful against inflammatory and allergic diseases |
| 01/08/2013 | CA2655644C Solution and method to reduce, treat and/or prevent oxidative stress and cell activation |
| 01/08/2013 | CA2654054C Pharmaceutical composition comprising amlodipine and losartan |
| 01/08/2013 | CA2653941C Substituted amino purine derivatives and uses thereof |
| 01/08/2013 | CA2642668C Indole-3-carboxylic acid amide and ester compounds bearing phenyl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 01/08/2013 | CA2642665C Anti-cancer pharmaceutical composition |
| 01/08/2013 | CA2630460C Heteroaryl substituted piperidine derivatives as l-cpt1 inhibitors |
| 01/08/2013 | CA2617510C Use of iron (iii) complex compounds for the preparation of a medicament for oral treatment of iron deficiency states in patients with chronic inflammatory bowel disease |
| 01/08/2013 | CA2614345C Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same |
| 01/08/2013 | CA2611435C Novel triterpenic acid derivative and preparation for external application for skin comprising the same |
| 01/08/2013 | CA2609595C Preventive and/or therapeutic agents for diabetic vascular disorders and respiratory disorders |
| 01/08/2013 | CA2600276C Polyphenol coxib combinations and methods |
| 01/08/2013 | CA2590511C Pharmaceutical combinations of an angiotensin receptor antagonist and an nep inhibitor |
| 01/08/2013 | CA2590333C Tetracyclic imidazo-benzodiazepines as gaba receptors modulators |
| 01/08/2013 | CA2586135C Compositions and processes for preparing 13-deoxy-anthracyclines |
| 01/08/2013 | CA2585560C Use of acetyl l-carnitine for the treatment of fibromyalgic syndrome |
| 01/08/2013 | CA2585359C Gaba-steroid antagonists and their use for the treatment of cns disorders |
| 01/08/2013 | CA2582262C Medium-chain length fatty alcohols as stimulators of hematopoiesis |
| 01/08/2013 | CA2581939C Nitric oxide-releasing diazeniumdiolated acrylonitrile-based polymers, and compositions, medical devices, and uses thereof |
| 01/08/2013 | CA2578441C Pyrimidine sulphonamide derivatives as chemokine receptor modulators |
| 01/08/2013 | CA2578302C Composition and method for inducing or restoring locomotor functions in an animal |
| 01/08/2013 | CA2572671C Cytoxan antibodies and immunoassay |
| 01/08/2013 | CA2571884C Hyaluronic acid in the enhancement of lens regeneration |
| 01/08/2013 | CA2569514C Oral preparations and process for production thereof |
| 01/08/2013 | CA2569125C Pyrrolopyridine derivatives and their use as crth2 antagonists |
| 01/08/2013 | CA2567574C Benzotriazine inhibitors of kinases |
| 01/08/2013 | CA2566369C Pentenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof |
| 01/08/2013 | CA2566155C 1-aza-bicyclo[3.3.1]nonanes |
| 01/08/2013 | CA2565968C Treatment of t-cell lymphoma using 10-propargyl-10-deazaaminopterin |
| 01/08/2013 | CA2565013C Method for producing pentacyclic taxans |
| 01/08/2013 | CA2563388C Microrna and methods for inhibiting same |
| 01/08/2013 | CA2562571C Novel androgens |
| 01/08/2013 | CA2561876C Antimicrobial compositions and methods for their use |
| 01/08/2013 | CA2559377C Derivatives of genkwanin and sakuranetin, cosmetic and therapeutic use thereof and preparation method of same |
| 01/08/2013 | CA2559188C Hyaluronic acid-methotrexate conjugate |
| 01/08/2013 | CA2558771C Multiple promoter expression cassettes for simultaneous delivery of rnai agents |
| 01/08/2013 | CA2558764C New association between agomelatine and a thymoregulator and the pharmaceutical compositions that contain it |
| 01/08/2013 | CA2557372C Diaminopyrimidines as p2x3 and p2x2/3 antagonists |
| 01/08/2013 | CA2546653C 3-aminopyrrolidone derivatives |
| 01/08/2013 | CA2546115C Solid dispersions or solid dispersion pharmaceutical preparations of phenylalanine derivatives |
| 01/08/2013 | CA2545513C Solid pharmaceutical preparation form |
| 01/08/2013 | CA2544500C Use of haloarylpyrazole compounds in the control of parasite infestation on animals |
| 01/08/2013 | CA2544291C Transdermal drug delivery method and system |
| 01/08/2013 | CA2543318C Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto |
| 01/08/2013 | CA2527420C Compounds, methods and pharmaceutical compositions for inhibiting parp |
| 01/08/2013 | CA2526530C (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent |
| 01/08/2013 | CA2521987C Methods and compositions for increasing the anaerobic working capacity in tissues |
| 01/08/2013 | CA2521879C Process for resolving amines that are useful for the treatment of disorders associated with insulin resistance syndrome |
| 01/08/2013 | CA2515160C Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis |
| 01/08/2013 | CA2513260C Oral compositions of fenretinide having increased bioavailability and methods of using the same |
| 01/08/2013 | CA2510337C Topoisomerase-targeting agents |
| 01/08/2013 | CA2507710C Tricyclic pyrazole derivatives and their use as cb1 or cb2 modulators |
| 01/08/2013 | CA2501389C Remedies or preventives for frequent urination or urinary incontinence and morphinan derivatives having nitrogen-containing heterocyclic group |
| 01/08/2013 | CA2501201C Gastric acid secretion inhibiting composition |
| 01/08/2013 | CA2490121C Modified phospholipids |
| 01/08/2013 | CA2489004C Agonistic binding molecules to the human ox40 receptor |
| 01/08/2013 | CA2485081C Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 01/08/2013 | CA2478731C Carbamates as hiv protease inhibitors |
| 01/08/2013 | CA2478065C Macrocyclic compounds useful as pharmaceuticals |
| 01/08/2013 | CA2470262C Glycoconjugates and their use as potential vaccines against infection by shigella flexneri |
| 01/08/2013 | CA2468539C Delivery of medicaments to the nail |
| 01/08/2013 | CA2466148C Medical compositions for intravesical treatment of bladder cancer |
| 01/08/2013 | CA2447671C Trisubstituted-n-[(1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors |
| 01/08/2013 | CA2441577C Therapeutic agents for inflammatory bowel diseases |
| 01/08/2013 | CA2428782C Medicine based on anti-hyperglycaemic microcapsules with prolonged release and its method of preparation |
| 01/08/2013 | CA2414064C Clear aqueous anaesthetic composition |
| 01/08/2013 | CA2409873C Hcv variants |
| 01/08/2013 | CA2388337C Method of inducing and/or enhancing an immune response to tumor antigens |
| 01/08/2013 | CA2377207C Combinations for introducing nucleic acids into cells |
| 01/08/2013 | CA2341777C Neutral amino acid transporter and gene thereof |
| 01/08/2013 | CA2323451C Skin conditioner |
| 01/08/2013 | CA2305681C Apoptosis-related compounds and their use |
| 01/08/2013 | CA2299630C Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 01/08/2013 | CA2285394C Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases |
| 01/08/2013 | CA2224702C Stable hydroalcoholic compositions |